Holen Sie sich die Stockscreener-App
3.51
2.93%
0.10
Schlusskurs vom Vortag:
$3.41
Offen:
$3.42
24-Stunden-Volumen:
3.48M
Relative Volume:
0.71
Marktkapitalisierung:
$1.05B
Einnahmen:
$38.03M
Nettoeinkommen (Verlust:
$-146.40M
KGV:
-6.75
EPS:
-0.52
Netto-Cashflow:
$-121.38M
1W Leistung:
-4.88%
1M Leistung:
-37.10%
6M Leistung:
+76.38%
1J Leistung:
+29.04%
1-Tages-Spanne:
$3.33
$3.55
1-Wochen-Bereich:
$3.33
$3.83
52-Wochen-Spanne:
$1.8906
$6.515
Abcellera Biologics Inc Stock (ABCL) Company Profile
Firmenname
Abcellera Biologics Inc
Sektor
Branche
Telefon
(604) 559-9005
Adresse
150 W 4TH AVENUE, VANCOUVER
Vergleichen Sie ABCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
3.51 | 1.02B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-07-07 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-02-28 | Eingeleitet | Cowen | Outperform |
| 2022-12-15 | Eingeleitet | Goldman | Buy |
| 2022-11-16 | Eingeleitet | Truist | Buy |
| 2021-12-21 | Eingeleitet | The Benchmark Company | Buy |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-01-05 | Eingeleitet | Berenberg | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-05 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-05 | Eingeleitet | Stifel | Buy |
Alle ansehen
Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten
How AbCellera Biologics Inc. (8QQ) stock correlates with oil marketsJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Is AbCellera Biologics Inc a good long term investmentStock Price Targets & Low Risk Wealth Building - earlytimes.in
Is AbCellera Biologics Inc. (8QQ) stock safe for risk averse investors2025 Fundamental Recap & AI Driven Stock Reports - newser.com
How AbCellera Biologics Inc. (8QQ) stock compares with market leadersJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Will AbCellera Biologics Inc. (8QQ) stock outperform energy sector in 2025Market Trend Summary & High Conviction Buy Zone Alerts - newser.com
How AbCellera Biologics Inc. (8QQ) stock reacts to weak economy2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
Is AbCellera Biologics Inc. (8QQ) stock at risk of policy regulationJobs Report & Daily Entry Point Alerts - newser.com
Can AbCellera Biologics Inc. (8QQ) stock resist broad market declinesMarket Volume Report & Accurate Intraday Trade Tips - newser.com
AbCellera Biologics’ Earnings Call: Key Insights - MSN
How AbCellera Biologics Inc. stock reacts to Fed rate cutsAnalyst Upgrade & Expert Curated Trade Setups - newser.com
Is a relief rally coming for AbCellera Biologics Inc. holdersDollar Strength & Fast Gain Stock Trading Tips - newser.com
What’s next for AbCellera Biologics Inc. stock priceQuarterly Investment Review & Capital Efficient Trade Techniques - newser.com
Will AbCellera Biologics Inc. stock reach Wall Street targetsWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com
What makes AbCellera Biologics Inc. (8QQ) stock appealing to growth investors2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Is AbCellera Biologics Inc. (8QQ) stock considered safe haven2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
AbCellera Biologics Inc. (ABCL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is AbCellera Biologics Inc. (8QQ) stock dividend growth reliableMarket Sentiment Summary & High Return Trade Opportunity Guides - newser.com
Why AbCellera Biologics Inc. (8QQ) stock stays on buy listsQuarterly Investment Review & Low Risk Investment Opportunities - newser.com
Real time breakdown of AbCellera Biologics Inc. stock performanceDollar Strength & Safe Investment Capital Preservation Plans - newser.com
Will AbCellera Biologics Inc. stock maintain momentum in 2025Weekly Gains Summary & Safe Entry Point Identification - newser.com
Will AbCellera Biologics Inc. (8QQ) stock hit Wall Street targetsAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will AbCellera Biologics Inc. see short term momentum2025 Top Decliners & AI Driven Stock Reports - newser.com
Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):